In the exact same yr the ITC also claimed on their endeavours in the direction of the circulation syntheses of two guide compounds claimed previously by AstraZeneca. The 1st one particulars the circulation synthesis of a strong 5HT1B antagonist (28) that was assembled by way of a five step ongoing synthesis including a SNAr reaction, heterogeneous